Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis

Michaela E Johnson,Benjamin Stecher,Viviane Labrie,Lena Brundin,Patrik Brundin,Michaela E. Johnson
DOI: https://doi.org/10.1016/j.tins.2018.09.007
2019-01-01
Trends in Neurosciences
Abstract:We hypothesize that Parkinson's disease (PD) pathogenesis can be divided into three temporal phases. During the first phase, 'triggers', such as viral infections or environmental toxins, spark the disease process in the brain and/or peripheral tissues. Triggers alone, however, may be insufficient, requiring 'facilitators' like peripheral inflammation for PD pathology to develop. Once the disease manifests, 'aggravators' spur further neurodegeneration and exacerbate symptoms. Aggravators are proposed to include impaired autophagy and cell-to-cell propagation of α-synuclein pathology. We believe clinical trials need to consider these three phases and target potential therapies at the appropriate stage of the disease process in order to be effective.
neurosciences
What problem does this paper attempt to address?